ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
26 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
26
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
7 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
finelinestyle
|
10K |
3.7M |
3 |
13/03/24 |
13/03/24 |
General
|
10K
|
3.7M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
23 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
finelinestyle
|
21 |
6.8K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
21
|
6.8K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
1 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
20K
|
6.9M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
3 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
20K
|
6.9M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
finelinestyle
|
821 |
205K |
19 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
821
|
205K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
finelinestyle
|
208 |
84K |
3 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
208
|
84K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
finelinestyle
|
508 |
120K |
9 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
120K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
20 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
20K
|
6.9M
|
20
|
|
ASX - By Stock
|
BTI |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
finelinestyle
|
9 |
2.9K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
9
|
2.9K
|
0
|
|
ASX - By Stock
|
BTI |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
finelinestyle
|
9 |
2.9K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
9
|
2.9K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
finelinestyle
|
508 |
120K |
32 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
508
|
120K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
finelinestyle
|
231 |
64K |
1 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
231
|
64K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
finelinestyle
|
231 |
64K |
1 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
231
|
64K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
7 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
1 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
20K
|
6.9M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
0 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
20K
|
6.9M
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
5 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
finelinestyle
|
450 |
145K |
36 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
145K
|
36
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Investor Information Sessions
|
|
finelinestyle
|
209 |
65K |
10 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
209
|
65K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
finelinestyle
|
592 |
183K |
14 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
592
|
183K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
finelinestyle
|
592 |
183K |
17 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
592
|
183K
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
4 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
20K
|
6.9M
|
4
|
|
ASX - By Stock
|
FSG |
Re:
FSG Chart Thread
|
|
finelinestyle
|
77 |
23K |
2 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
77
|
23K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
22 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20K
|
6.9M
|
22
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
13 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20K
|
6.9M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Investor Information Sessions
|
|
finelinestyle
|
209 |
65K |
2 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
209
|
65K
|
2
|
|
ASX - By Stock
|
MCL |
Re:
78 degree recall
|
|
finelinestyle
|
6 |
2.5K |
2 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
6
|
2.5K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Investor Information Sessions
|
|
finelinestyle
|
209 |
65K |
33 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
209
|
65K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Investor Information Sessions
|
|
finelinestyle
|
209 |
65K |
1 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
209
|
65K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Investor Information Sessions
|
|
finelinestyle
|
209 |
65K |
5 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
209
|
65K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
finelinestyle
|
592 |
183K |
8 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
592
|
183K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
finelinestyle
|
35 |
13K |
19 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
35
|
13K
|
19
|
|
ASX - By Stock
|
BTI |
Re:
Ann: Net Tangible Asset Backing
|
|
finelinestyle
|
2 |
1.0K |
2 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
2
|
1.0K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
11 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
20K
|
6.9M
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
3 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
20K
|
6.9M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives Additional $1.66m R&D Tax Refund for FY 2022
|
|
finelinestyle
|
14 |
4.9K |
12 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
14
|
4.9K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race executes agreement with Ardena for GMP manufacturing
|
|
finelinestyle
|
35 |
13K |
10 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
35
|
13K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
finelinestyle
|
4.0K |
1.8M |
0 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
4.0K
|
1.8M
|
0
|
|
ASX - By Stock
|
MCL |
Re:
Ann: Outcomes of Board-led strategic review
|
|
finelinestyle
|
19 |
9.1K |
7 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
19
|
9.1K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
20 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
20K
|
6.9M
|
20
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
finelinestyle
|
20K |
6.9M |
20 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
20K
|
6.9M
|
20
|
|
ASX - By Stock
|
BTI |
Re:
Ann: Net Tangible Asset Backing
|
|
finelinestyle
|
17 |
7.8K |
2 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
17
|
7.8K
|
2
|
|
ASX - By Stock
|
BTI |
Re:
Ann: Change of Director's Interest Notice - David Kirk
|
|
finelinestyle
|
1 |
639 |
2 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
1
|
639
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
finelinestyle
|
10K |
3.7M |
48 |
06/06/23 |
06/06/23 |
General
|
10K
|
3.7M
|
48
|
|
ASX - By Stock
|
MCL |
Re:
Ann: MCL appoints new Chair, commences strategic review
|
|
finelinestyle
|
1 |
1.0K |
1 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
1
|
1.0K
|
1
|
|
ASX - By Stock
|
BTI |
Re:
Ann: Net Tangible Asset Backing
|
|
finelinestyle
|
10 |
3.8K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
10
|
3.8K
|
2
|
|
ASX - By Stock
|
MCL |
Re:
General Chat
|
|
finelinestyle
|
92 |
58K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
92
|
58K
|
2
|
|